Literature DB >> 6405604

New nitrate delivery systems: buccal nitroglycerin.

J Abrams.   

Abstract

BN, a new nitrate formulation, has recently been made available. The main advantages of this medication is the combination of prompt onset of action, comparable to that of sublingual NTG, and sustained activity that persists for many hours. The tablet remains pharmacologically effective as long as it remains in the buccal pouch. A variety of studies indicate that BN is well tolerated by patients, acts promptly to provide protection against anginal pain, and has sustained efficacy that persists for 2 to 6 hours. Clinical investigations using serial treadmill testing in patients with angina demonstrate clinical effectiveness and bioactivity of BN beginning within minutes and lasting over 4 hours. The potential advantages of this preparation are discussed, and the formulation is compared to other available longacting nitrates. BN is an effective new addition to the nitrate armamentarium.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405604     DOI: 10.1016/0002-8703(83)90251-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

Review 1.  The medical treatment of angina pectoris.

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1987-12

Review 2.  Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.

Authors:  J Abrams
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 3.  Prophylactic nitrate therapy in angina pectoris--is there an optimal treatment regimen?

Authors:  G Olsson; J Allgén
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

4.  New transdermal and transmucosal nitroglycerin delivery systems in patients with ischaemic heart disease.

Authors:  V I Metelitsa; V K Piotrovskii; O S Ryabokon; S V Blagodatskikh
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Assessment of left ventricular function in coronary artery disease with the nuclear probe during intervention studies.

Authors:  A Lahiri; M J Bowles; R I Jones; J C Crawley; E B Raftery
Journal:  Br Heart J       Date:  1984-10

6.  Buccal versus intravenous nitroglycerin in unstable angina pectoris.

Authors:  M Dellborg; G Gustafsson; K Swedberg
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.